Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05716958 · ClinicalTrials.gov registry record
Multi-Reader, Multi-Case, Cross-Over, Retrospective Study to Evaluate Effectiveness of Lunit INSIGHT DBT
A clinical trial of Breast Cancer, sponsored by Lunit.
- Completed
- Registry status
- 262
- Enrollment target
- 1
- Study location
NCT05716958: Completed study of Breast Cancer, sponsored by Lunit.
NCT05716958 is a study of Breast Cancer that has completed, run by Lunit. The registered enrollment target is 262 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05716958, a study of Breast Cancer, has completed, sponsored by Lunit.
- COMPLETED
- Registry status
- 262 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to evaluate Effectiveness of Lunit INSIGHT DBT in the assistance of detection and diagnosis of breast cancer during 3D mammography interpretation
Primary Outcome
Patient-level LOS (Level of Suspicion) area under the ROC (Receiver Operating Characteristic) curve
Conditions Studied
Interventions
- RADIATION Digital Breast Tomosynthesis
Study Locations (1)
Maryland
- Anne Arundel Medical Center - Annapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 262 participants |
| Start Date | 2022-03-22 |
| Est. Completion | 2023-02-28 |
What the finished NCT05716958 record still lists
NCT05716958 is an observational study that tracks outcomes without assigning an intervention. The registered 262 participants enrollment target is mid-sized for trials with a published cap, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (91% lower).
The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Digital Breast Tomosynthesis is the first listed.
NCT05716958 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT05716958 about?
NCT05716958 is a clinical study titled "Multi-Reader, Multi-Case, Cross-Over, Retrospective Study to Evaluate Effectiveness of Lunit INSIGHT DBT". This study aims to evaluate Effectiveness of Lunit INSIGHT DBT in the assistance of detection and diagnosis of breast cancer during 3D mammography interpretation
What is the current status of trial NCT05716958?
This trial is currently completed. The enrollment target is 262 participants. The study started on 2022-03-22. Estimated completion is 2023-02-28.
What conditions does trial NCT05716958 study?
This clinical trial studies the following conditions: Breast Cancer.
What interventions are being tested in trial NCT05716958?
The interventions under investigation include: Digital Breast Tomosynthesis (RADIATION).
Who is sponsoring clinical trial NCT05716958?
This trial is sponsored by Lunit, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05716958 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05716958's enrollment target sits among peer trials
262 312th of 1224 higher than 913 of 1,224 other Breast Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Surviving Daily Life
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03713268 · 262 participants
Intraoperative OCT Guidance of Intraocular Surgery II
- NCT06074380 · 262 participants · Phase 4
Non Inferiority Trial Investigating Surfactants Administered Via MIST
- NCT06293703 · 262 participants · NA
Effect of Limb Length Ratio on Roux-en-Y Gastric Bypass Outcomes (CLIMB II Study)
- NCT06780137 · 262 participants · Phase 1
A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI